Efficacy and Safety in the KEYNOTE-966 Study of Pembrolizumab (Pembro) Plus Gemcitabine and Cisplatin (gem/cis) for Advanced Biliary Tract Cancer (BTC): Impact of Hepatitis B Virus (HBV) Infection

Simple item page
dc.contributor.author Yau, T.
dc.contributor.author Chan, S. L.
dc.contributor.author Kelley, R. K.
dc.contributor.author Finn, R. S.
dc.contributor.author Yoo, C.
dc.contributor.author Furuse, J.
dc.contributor.author Qin, S.
dc.date.accessioned 2025-08-25T16:58:22Z
dc.date.available 2025-08-25T16:58:22Z
dc.date.issued 2024
dc.description.sponsorship Merck Sharp Dohme LLC en_US
dc.description.sponsorship Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA. en_US
dc.identifier.doi 10.1016/j.annonc.2024.10.169
dc.identifier.issn 0923-7534
dc.identifier.issn 1569-8041
dc.identifier.uri https://doi.org/10.1016/j.annonc.2024.10.169
dc.identifier.uri https://hdl.handle.net/20.500.14365/6348
dc.language.iso en en_US
dc.publisher Elsevier en_US
dc.relation.ispartof Annals of Oncology en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.title Efficacy and Safety in the KEYNOTE-966 Study of Pembrolizumab (Pembro) Plus Gemcitabine and Cisplatin (gem/cis) for Advanced Biliary Tract Cancer (BTC): Impact of Hepatitis B Virus (HBV) Infection en_US
dc.type Conference Object en_US
dspace.entity.type Publication
gdc.author.wosid Yau, Thomas/B-3429-2011
gdc.author.wosid Vogel, Arndt/A-8437-2012
gdc.author.wosid Park, Juno/Mvu-2069-2025
gdc.author.wosid Pelzer, Uwe/Aax-1957-2020
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access metadata only access
gdc.coar.type text::conference output
gdc.collaboration.industrial true
gdc.description.department İzmir Ekonomi Üniversitesi en_US
gdc.description.departmenttemp [Yau, T.] Univ Hong Kong, Med, Hong Kong, Peoples R China; [Chan, S. L.] Chinese Univ Hong Kong, Sir Yue Kong Pao Ctr, Dept Clin Oncol, State Key Lab Translat Oncol, Hong Kong, Peoples R China; [Kelley, R. K.] Univ Calif San Francisco, Med Hematol Oncol, San Francisco, CA 94143 USA; [Finn, R. S.] Univ Calif Los Angeles, Geffen Sch Med, Div Hematol Oncol, Los Angeles, CA USA; [Yoo, C.] Univ Ulsan, Asan Med Ctr, Oncol, Coll Med, Seoul, South Korea; [Furuse, J.] Kyorin Univ Hosp, Gastroentel, Tokyo, Japan; [Furuse, J.] Kanagawa Canc Ctr, Yokohama, Kanagawa, Japan; [Ren, Z.] Fudan Univ, Zhongshan Hosp, Hepat Oncol, Shanghai, Peoples R China; [Klumpen, H. J.] Univ Amsterdam, Med Oncol, Med Ctr, Amsterdam, Netherlands; [Ozaka, M.] Japanese Fdn Canc Res JFCR, Canc Inst Hosp, Gastroenterol, Tokyo, Japan; [Pelzer, U.] Humboldt Univ, Freie Univ Berlin, Charite Campus Mitte, Dept Hematol Oncol & Canc Immunol,Berlin Inst Hlt, Berlin, Germany; [Arslan, C.] Izmir Econ Univ, Med Oncol, Med Point Hosp, Izmir, Turkiye; [Park, J. O.] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Edeline, J.] Ctr Eugene Marquis, Med Oncol, Rennes, France; [Valle, J. W.] Univ Manchester, Div Canc Sci, Manchester, Lancs, England; [Valle, J. W.] Cholangiocarcinoma Fdn, Salt Lake City, UT USA; [Ueno, M.] Kanagawa Canc Ctr, Gasteroenterol, Yokohama, Kanagawa, Japan; [Vogel, A.] Hannover Med Sch, Hepatol Oncol, Hannover, Germany; [Starkopf, L.; Malhotra, U.; Siegel, A. B.] Merck & Co Inc, Med Oncol, Rahway, NJ USA; [Qin, S.] Peoples Liberat Army, Ctr Canc, Med Oncol, Nanjing, Peoples R China en_US
gdc.description.endpage S1462 en_US
gdc.description.publicationcategory Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q1
gdc.description.startpage S1462 en_US
gdc.description.volume 35 en_US
gdc.description.woscitationindex Science Citation Index Expanded - Conference Proceedings Citation Index - Science
gdc.description.wosquality Q1
gdc.identifier.openalex W4405134889
gdc.identifier.wos WOS:001401985200139
gdc.index.type WoS
gdc.oaire.diamondjournal false
gdc.oaire.impulse 0.0
gdc.oaire.influence 2.4895952E-9
gdc.oaire.isgreen false
gdc.oaire.popularity 2.3737945E-9
gdc.oaire.publicfunded false
gdc.openalex.collaboration International
gdc.openalex.fwci 0.0
gdc.openalex.normalizedpercentile 0.42
gdc.opencitations.count 0
gdc.wos.citedcount 0
relation.isOrgUnitOfPublication e9e77e3e-bc94-40a7-9b24-b807b2cd0319
relation.isOrgUnitOfPublication.latestForDiscovery e9e77e3e-bc94-40a7-9b24-b807b2cd0319

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection